SCALE Performance

KLOW Blend Pen certificate of analysis, lot PL-2610-113

Certificate PL-26-00227 reports the release tests for KLOW Blend Pen lot PL-2610-113: 99.40% purity by reverse-phase HPLC and identity confirmed by LC-MS, tested October 6, 2026. The lot number printed on each unit matches this certificate.

Certificate numberPL-26-00227
Lot numberPL-2610-113
CompoundKLOW Blend Pen 240 mg
Purity (RP-HPLC)99.40%
Identity (LC-MS)Conforms (4 / 4)
MethodRP-HPLC (UV 214 nm) + LC-MS
TestedOctober 6, 2026
Retest byOctober 5, 2028
Tested byManufacturer’s in-house laboratory (not an independent third-party test)
ConclusionConforms

Tests run on this lot

TestMethodSpecificationResult
GHK-Cu: purity · largest impurity · massRP-HPLC 214 nm (area%); LC-MS, ESI+≥ 99.0% · ≤ 1.0% · ± 1.0 Da99.73% · 0.15% · 401.89 Da (PASS)
BPC-157: purity · largest impurity · massRP-HPLC 214 nm (area%); LC-MS, ESI+≥ 99.0% · ≤ 1.0% · ± 1.0 Da99.40% · 0.44% · 1,419.50 Da (PASS)
TB-500: purity · largest impurity · massRP-HPLC 214 nm (area%); LC-MS, ESI+≥ 99.0% · ≤ 1.0% · ± 1.0 Da99.48% · 0.34% · 4,963.47 Da (PASS)
KPV: purity · largest impurity · massRP-HPLC 214 nm (area%); LC-MS, ESI+≥ 99.0% · ≤ 1.0% · ± 1.0 Da99.82% · 0.10% · 342.44 Da (PASS)
Assay (total blend)Assay vs label claim76–84 mg/mL81.93 mg/mL (PASS)
Bacterial endotoxinLAL, kinetic≤ 5.0 EU/mg0.285 EU/mg (PASS)
SterilityUSP <71>, 14-dayNo growthNo growth (PASS)

What these results mean

HPLC purity is the share of UV-detectable material that elutes as the target compound; it is not the same as net peptide content, which also accounts for water and counter-ions. Identity means the measured mass matched the mass calculated for the compound. A certificate reports only the tests run on this lot; endotoxin, sterility and contaminant panels are not part of standard lot release. How to read a certificate of analysis.

KLOW Blend Pen · Verify this certificate · All certificates

All KLOW Blend Pen certificates

All products currently listed on this site are for research purposes only. Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption. Products have not been evaluated by the U.S. Food and Drug Administration and are not intended to diagnose, treat, cure or prevent any disease.